Guggenheim Partners & United States — United States Securities and Exchange Commission
6 shared events · Importance 5 · Last updated Apr 21, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
Guggenheim Partners: Guggenheim Partners acted as the sole book-running manager for the IPO of BHAV Acquisition Corp, facilitating the offering and demonstrating its role in capital markets.
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission declared the registration statement for BHAV Acquisition Corp's IPO effective, fulfilling its regulatory oversight role.
Apr 16, 2026 · 6 articles
Business
Guggenheim Partners: Guggenheim Partners is acting as a book-running manager for the public offering by Forte Biosciences.
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission declared effective the Registration Statement on Form S-3 for Forte Biosciences's public offering.
Apr 08, 2026 · 7 articles
Business
Guggenheim Partners: Guggenheim Partners acted as a bookrunner for the offering.
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission declared the Registration Statement on Form S-1 effective for the offering.
Apr 06, 2026 · 8 articles
Business
Guggenheim Partners: Guggenheim Partners is acting as a joint book-running manager for the public offering of Spyre Therapeutics' common stock.
Apr 13, 2026 · 7 articles
Business
Guggenheim Partners: Guggenheim Partners is serving as financial advisor to Acelyrin for the merger.
Mar 04, 2025 · 7 articles
NEWSDESK
Explore this relationship live
Track how Guggenheim Partners and United States — United States Securities and Exchange Commission interact across events, view sentiment trends, and discover connected entities.
Open Dashboard